Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsPRNewsWire • 03/26/26
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026PRNewsWire • 03/16/26
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026PRNewsWire • 03/12/26
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible SecuritiesPRNewsWire • 02/04/26
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard®PRNewsWire • 01/21/26
Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer DetectionPRNewsWire • 12/09/25
Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking HonoreePRNewsWire • 11/20/25
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumPRNewsWire • 11/13/25
PAVmed Provides Business Update and Reports Third Quarter 2025 Financial ResultsPRNewsWire • 11/13/25
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial ResultsPRNewsWire • 11/12/25
PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025PRNewsWire • 10/30/25
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025PRNewsWire • 10/29/25
PAVmed Subsidiary, Veris Health and The Ohio State University Comprehensive Cancer Center Launch Commercial Phase of Strategic Partnership AgreementPRNewsWire • 10/07/25
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government AffairsPRNewsWire • 09/16/25
Lucid Diagnostics to Participate in the Cantor Global Healthcare Conference 2025PRNewsWire • 08/27/25
PAVmed Signs Letter of Intent to License Groundbreaking Endoscopic Esophageal Imaging TechnologyPRNewsWire • 08/26/25